Apoptosis of cardiomyocytes significantly contributes to the development of post-ischaemic cardiomyopathy. Although mitochondria have been suggested to play a crucial role in this process, the precise mechanisms controlling the mitochondria-dependent apoptosis in cardiomyocytes under ischaemia/reperfusion are still poorly understood. Here we aimed to analyse the role of the soluble adenylyl cyclase (sAC).
Introduction
Cardiac ischaemia/reperfusion results in a progressive loss of cardiomyocytes, ultimately leading to heart failure. Aside from necrosis and autophagy, numerous reports indicate a pivotal role of apoptosis in cardiomyocyte death during ischaemia/reperfusion. 1 -3 Within several signalling pathways, cAMP-dependent signalling plays a substantial role in mediating apoptotic cell death induced by various stress factors 4, 5 including ischaemia/reperfusion. 6 Until now the contribution of this pathway in cardiac apoptosis was exclusively attributed to the activation of the b-receptor-coupled transmembrane adenylyl cyclase (tmAC). The subsequent diffusion of cAMP throughout the cytosol makes it difficult to selectively activate distally localized targets, e.g. within mitochondria, without also activating more proximal targets within the plasmalemma. Such a simple diffusion of cAMP would likely diminish specificity, selectivity, and signal strength. This model is further complicated by the presence of phosphodiesterases degrading cAMP and preventing its diffusion.
Apart from the tmAC, a second source of cAMP, the type 10 soluble adenylyl cyclase (sAC), was demonstrated for mammalian cells. 7 The cytosolic localization of sAC provides both specificity and selectivity by permitting generation of cAMP in close proximity to intracellular targets. Whether sAC participates in ischaemia/reperfusion-induced cardiomyocyte apoptosis is unknown. It has been shown that sAC co-localizes with mitochondria. 8, 9 Furthermore, the translocation of sAC from cytosol to mitochondria has been found under extracellular acidosis, 9 which is an important component of ischaemia. Aside from an alteration of the intracellular sAC localization, ischaemic stress may also affect the activity of sAC. Indeed, sAC activity is strongly dependent on the cytosolic Ca 2+ concentration. 10 Therefore, cytosolic Ca 2+ overload observed in cardiomyocytes under ischaemia or anoxia 11, 12 may lead to activation of sAC. Since mitochondria play a crucial role in ischaemia/reperfusion-induced cardiomyocyte apoptosis, 13 we hypothesized that sAC-dependent cAMP-signalling may contribute to the ischaemia/reperfusion-induced apoptosis by modulating the mitochondrial pathway of apoptosis.
Methods
The investigation conforms with the Directive 2010/63/EU of the European Parliament and the approval for animal research was granted by the ethic review board of the Ruhr-University Bochum.
Cell isolation and culture
Ventricular cardiomyocytes were isolated from male Wistar rats by perfusion of hearts with collagenase type II (300 U/mL) and cultured, as previously described. 12, 14 For this purpose adult male rats were euthanized using deep isoflurane (5%) anaesthesia, hearts were rapidly excised, washed with ice-cold 0.9% NaCl and connected to the perfusion system. Anaesthesia depth was monitored by limb withdrawal using toe pinching. To separate cardiomyocytes from non-cardiac cells, cardiomyocytes were sedimented by low force and short centrifugation (5 g, 1 min, four times) and finally without centrifugation in medium containing 4% bovine serum albumin. To prevent growth of non-myocytes, medium was supplemented with 10 mmol/L cytosine-b-D-arabinofuranoside. After 1 h of plating, cells were washed with culture medium (2% foetal calf serum) to remove non-attached cells. A high purity of cardiomyocyte culture (.93%) was confirmed by light microscopy. Experiments were performed on the third day after preparation.
Experimental protocols
Cardiomyocytes were exposed to simulated in vitro ischaemia (SI) consisting of glucose-free anoxia at pH 6.4 as previously described. 12 After 3 h of SI, simulated reperfusion (SR) was performed by returning cells into the basic culture medium. Cardiomyocytes not exposed to SI/SR, but subjected to equal washing procedure with basic culture medium, were used as controls. KH7 (20 mmol/L, Cayman Chemical) and KH7.14 (20 mmol/L, kindly provided by Dr J. Buck, Cornell University, NY, USA), Bax-inhibitory peptide (V5) or its inactive analogue (100 mmol/L; Calbiochem), 2
′ -monophosphorothioate (Rp-cAMP, 100 mmol/L, Calbiochem) were applied during SI or SR. At the end of experiments, floating cells were collected and used together with attached cells for further analyses.
Analysis of DNA fragmentation
DNA isolation was performed as previously described. 15 Five micrograms of DNA were loaded onto 1.5% agarose gel followed by electrophoresis. DNA laddering was visualized with 0.5 mg/mL ethidium bromide.
Western blotting
Equal amounts of total proteins (20 -40 mg) were separated on SDSpolyacrylamide gels and transferred to nitrocellulose membrane. Primary antibodies were sAC (clone R21 kindly provided by Dr J. Buck, Cornell University, NY), alpha-actinin, cytochrome c (Sigma), actin (Chemicon International), caspase-3, caspase-9, Bax (Cell Signaling), caspases-12 (Calbiochem), phospho-Bax-Thr(167) (AssayBiotech), and caspase-8 (BioVision). Specific bands were visualized after incubation with peroxidase-linked/horseradish peroxidase-labelled secondary antibodies by chemiluminescence using the ECL+ kit (Amersham Biosciences). Equivalent sample loading was confirmed by stripping membranes with Restore western blot stripping buffer (Pierce), followed by treatment with antibodies against actin.
Quantification of apoptotic nuclei by fluorescence microscopy
To identify chromatin condensation or fragmentation, cardiomyocytes were stained with 50 mg/mL Hoechst33342. 9 For quantitative assay, a blind analysis of 200 -300 cells from four to five randomized fields was used. Cells were scored as apoptotic when at least one stained nucleus produced unequivocal bright blue fluorescence due to chromatin condensation.
Analysis of lactate dehydrogenase in culture medium
Lactate dehydrogenase (LDH) activity in the cell culture medium was used as an indicator for necrosis and was determined applying the Cytotoxicity Detection Kit (Roche Applied Science). After each experiment culture medium was centrifuged at 500 g for 5 min at 48C and the supernatant was used for LDH analysis applying ELISA reader.
Detection of cellular reactive oxygen species
To examine reactive oxygen species (ROS) formation, cardiomyocytes were loaded 30 min prior to SR with DCF (2 ′ ,7 ′ -dichlorodihydrofluorescein diacetate, succinimidyl ester, 10 mmol/L, Invitrogen), a non-fluorescent dye, which is converted into the highly fluorescent DCF in the presence of free radicals. DCF fluorescence was analysed by excitation at 488 nm and emission at 530 nm applying ELISA reader. 
Detection of mitochondrial membrane potential

Mitochondria isolation
Mitochondria were isolated using the Qproteome Mitochondrial Isolation Kit (Qiagen). Lysed cells were centrifuged at 1000 g for 10 min. The resulting supernatant was centrifuged at 6000 g at 48C. After this centrifugation, the pellet was defined as the mitochondrial fraction and the supernatant as the cytosolic, mitochondria-free fraction. The purity of Soluble adenylyl cyclase controls apoptosis the cytosolic fraction was confirmed by the absence of Tim23 applying western blot analysis.
Construction of sAC shRNA adenovirusvector and transfer in myocytes
shRNA adenovirus vectors were constructed with the AdEasy Adenoviral Vector System. 17 The pAd-Track-CMV shuttle vector was used to insert the murine U6 promoter and the anti-sAC directed shRNA as a double stranded oligonucleotide using the Bgl II and KpnI restriction sites. The vector pmU6pro containing the murine U6snRNA promoter served as a template. To produce shRNA encoding vectors, the U6-promotor and the hairpin construct were fused using a universal 5 ′ U6 primer and a 3
′ primer including the siRNA (bold) and complementary U6 promoter sequences (italic):
′ . The underlined sequence corresponds to the hairpin loop. A randomized sequence (scrambled) based on the above sequence served as control. Adenovirus recombinant plasmids were generated by homologous recombination between pAd-Tracksh-sAC and pAd-Easy1 in E. coli to produce the recombinant viruses. The recombinant viruses were propagated in HEK293 cells and recovered after several freeze-thaw cycles. Cells were infected using 10 6 viral particles per millilitre culture medium. Efficiency of the sAC knock-down was examined by western blot analysis.
Cellular cAMP analysis
Analysis of the total cellular cAMP content was performed applying the cAMP (direct) Enzyme Immunoassay Kit (Assay Designs). The measured absorbance at 405 nm was used to calculate the concentration of cAMP, applying a calibration curve.
Statistical analysis
Data are given as means + SEM. Comparison of means between the groups was performed by one-way analysis of variance followed by the Holm-Sidak post hoc test. Statistical significance was accepted when P , 0.05.
Results
Inhibition of sAC during SI prevents SI/SR-induced cardiomyocyte apoptosis
Treatment with SI (3 h) alone had no effect on apoptosis (data not shown), whereas a marked caspase-3 cleavage ( Figure 1A and B), a significant rise in apoptotic cell number (16.1 + 1.5 vs. 3.7 + 1.5% in control, n ¼ 7, Figure 1C and see Supplementary material online, Figure S2 ) and DNA fragmentation (see Supplementary material online, Figure S1 ) were found after 6 h of SR.
To examine the role of sAC in cardiomyocyte apoptosis, a treatment with the selective sAC-inhibitor KH7 18 was applied. Treatment with 20 mmol/L KH7 during SI, but not during the SR, significantly reduced caspase-3 cleavage ( Figure 1A and B) and the number of apoptotic cells ( Figure 1C) . Furthermore, SI/SR-induced DNA fragmentation was prevented by treatment with KH7 during SI (see Supplementary material online, Figure S1 ).
To rule out unspecific side-effects of KH7 on apoptosis, additional treatment with its inactive analogue, i.e. KH7.14, was applied. In contrast to KH7, KH7.14 treatment had no effect on the cellular cAMP level (Figure 2A) , the caspase-3 cleavage ( Figure 2B) , and the apoptotic cell number ( Figure 2C) . Analysis of the necrotic cell death by LDH release revealed a rise of LDH activity in cell culture medium at the end of SR period, which was significantly reduced by treatment with the sAC inhibitor KH7, but not with its inactive analogue KH7.14 ( Figure 2C ). Neither KH7 nor KH7.14 had effects on caspase-3 cleavage, number of apoptotic cells and LDH release in control, normoxic cells (data not shown).
Mitochondria play an essential role in sAC-dependent apoptosis
Previous reports emphasized the importance of the extrinsic (death receptor) and the intrinsic (mitochondria or endoplasmic reticulum) pathways in ischaemia/reperfusion-induced apoptosis of cardiomyocytes. 19 In our model no activation of the death receptor pathway, examined by caspase-8 cleavage, could be detected under any experimental condition ( Figure 3A and B) . Similarly, SI alone or in the presence of KH7 had no effect on cleavage of caspases-12 (see Supplementary material online, Figure S3 ). In contrast, a marked rise of cytosolic cytochrome c and a cleavage of caspase-9 were found during SR, which was prevented by treatment with KH7, but not with its inactive analogue KH7.14 ( Figure 3C and D). Analysing the time course of cytosolic cytochrome c revealed only a moderate rise of cytochrome c at the end of SI, but a significant release of cytochrome c from mitochondria was found during the first 2 h of SR (see Supplementary material online, Figure S4 ). Interestingly, analysis of the subcellular distribution of sAC demonstrated a marked co-localization of the cyclase with mitochondria at the end of SI (see Supplementary material online, Figure S5 ). Although this finding does not necessarily indicate a causal role of the sAC translocation in induction of mitochondrial cytochrome c release, it nevertheless supports a potential role of sAC in the mitochondrial pathway of apoptosis.
To further substantiate the role of sAC in mitochondria-dependent apoptosis of cardiomyocytes, expression of sAC was suppressed by adenoviral transfection with shRNA, which reduced expression of the 50 kDa sAC protein by .80% (Figure 3E and F ) . Subsequent analysis of apoptosis demonstrated that SI/SR-induced cleavage of caspase-9 and -3 was significantly reduced by sAC knock-down ( Figure 3G and H ) . Thus, knock-down of sAC together with its pharmacological inhibition suggests a key role of sAC in the SI/SR-induced activation of the mitochondrial pathway of apoptosis.
Mitochondrial ROS formation is essential for sAC-dependent apoptosis
Mitochondria represent a main source of the ROS formation during reperfusion or reoxygenation, 20 which in turn can lead to mitochondrial injury and apoptosis. Analysing ROS formation in cardiomyocytes by applying the fluorescent dye DCF, we found a slight and sAC-independent rise of DCF fluorescence at the end of SI, which was markedly augmented during the first 60 min of SR ( Figure 4A ). The SR-induced ROS formation was significantly reduced by treating the cells during SI with the sAC inhibitor KH7, but not with its inactive analogue KH7.14. In addition, treating the cells during SR with 20 mmol/L rotenone, an inhibitor of complex I, or with 10 mmol/L TTFA, an inhibitor of complex II, also prevented ROS formation. Both inhibitors showed similar effects as the ROS scavenger NAC (5 mmol/L). These findings suggest mitochondria as the main source of the SR-induced ROS generation in our model. Similar to pharmacological inhibition of sAC with KH7, a knock-down of sAC significantly reduced ROS formation ( Figure 4B) . To prove a causal role of ROS in SR-induced apoptosis, cardiomyocytes were treated with the ROS scavenger NAC during SR. This treatment prevented SI/SR-induced caspase-9 and -3 cleavage ( Figure 4C) . Thus, sAC-dependent ROS formation during SR seems to play a causal role in activation of the mitochondrial pathway of apoptosis in cardiomyocytes.
sAC contributes to the injury of mitochondria during SI
Ischaemia-induced mitochondrial injury, usually accompanied by mitochondrial depolarization, has been shown to play an essential role in excessive ROS generation during reperfusion. 21 To examine the role of sAC in mitochondrial injury, mitochondrial membrane potential was measured by applying the fluorescent dye JC-1. SI led to a mitochondrial depolarization, which was significantly attenuated by the sAC inhibitor KH7, but not by its inactive analogue KH7.14 ( Figure 5A ).
SI-induced mitochondrial Bax translocation is sAC-and PKA-dependent and plays a causal role in post-anoxic apoptosis
Increasing evidence suggests an essential role of the pro-apoptotic protein Bax in triggering the mitochondrial pathway of apoptosis. 22 Analysing the role of Bax in our model we found a pronounced translocation of Bax from the cytosol to mitochondria under anoxic treatment, which was sAC-dependent ( Figure 5B) . To examine the role of Bax in SI/SR-induced ROS formation and apoptosis, a selective Bax inhibiting peptide was applied. Treatment with the Bax inhibiting peptide, but not with its inactive analogue, abolished the mitochondrial Bax translocation in anoxic cardiomyocytes (see Supplementary material online, Figure S6 ). Furthermore, Bax inhibiting peptide prevented SI/ SR-induced caspase-9 and -3 cleavage and ROS formation ( Figures 5C  and D) . Altogether, SI-induced translocation of Bax to mitochondria is a key causal event for ROS formation and apoptosis during SR. Since protein kinase A (PKA) is an important down-stream target for sAC and may promote mitochondrial Bax binding through Bax phosphorylation, 23 we analysed the potential contribution of this kinase in SI/SR-induced apoptosis and mitochondrial Bax translocation. Treatment with either the ATP-binding site inhibitor H89 (3 mmol/L) or with the cAMP-binding site inhibitor adenosine 3 ′ ,5 ′ -cyclic monophosphorothioate (Rp-cAMPS, 100 mmol/L) during SI abolished SI-induced mitochondrial Bax translocation ( Figure 6A and B) and SI/SR-induced caspase-9 and -3 cleavage ( Figure 6C and D) .
To substantiate the role of PKA in the mitochondrial Bax translocation, western blot analysis of Bax phosphorylation at Thr(167) was performed. We found that SI significantly increased Bax phosphorylation at Thr(167). Inhibition of sAC or PKA significantly reduced this effect of SI (see Supplementary material online, Figure S7 ).
Discussion
The aim of the present study was to examine whether sAC may contribute to the SI/SR-induced apoptosis of cardiomyocytes, and which (ii) The underlying signalling pathway consists of the sACand PKA-dependent phosphorylation and mitochondrial translocation of Bax during SI, which in turn leads to mitochondrial ROS formation followed by cytochrome c release and apoptosis during SR.
In the present study, an in vitro model of SI/SR on isolated adult rat cardiomyocytes was applied. This model of simulated ischaemia and reperfusion was characterized previously with respect to cytosolic ion homeostasis and hypercontracture. 12 In contrast to an in vivo model, the isolated cardiac cell model allows analysis of apoptotic mechanisms in cardiomyocytes independently from the effects of other cell types, e.g. endothelial cells. Furthermore, this model is free of excessive mechanical forces developing during reperfusion, i.e. hypercontracture, which has been shown to be a main cause of cardiomyocyte necrosis during reperfusion. 24, 25 Although findings obtained with an in vitro model may be only partly translated to the clinical setting, several similarities previously demonstrated for in vivo or ex vivo ischaemia/reperfusion models were found in the present study. Particularly, the previously shown triggering role of ischaemia and executing role of reperfusion 26, 27 as well as a key role of mitochondria 13, 28 have been demonstrated in our study.
Many efforts have been made to understand the underlying cellular mechanisms of ischaemia/reperfusion-induced apoptosis in cardiac cells. In the present study, the contribution of the cAMP-dependent signalling has been investigated. Although the involvement of this pathway in mediating apoptosis was demonstrated in several reports, the data are still controversial and both pro-and antiapoptotic effects of cAMP signalling have been found. 4, 5, 29, 30 The basis for this discrepancy is still unclear and may be due to differences in cell type or experimental model. Alternatively, a lack of specificity of the tmAC-induced signals, especially directed to distant intracellular targets like mitochondria, may be a cause for this discrepancy. Indeed, the majority of the studies investigated the role of cAMPsignalling pathway through activation of membrane-bound adenylyl cyclase, e.g. by forskolin or catecholamines, whereas the role of the intracellular localized sAC-pool of cAMP was not considered. Therefore, in the present study we focused on the role of this sAC in SI/SR-induced cardiomyocyte apoptosis. For this purpose, treatment with the selective sAC inhibitor KH7 18 or sAC-knock-down was applied. The both tools applied to suppress sAC activity support a key role of this cyclase in SI/SR-induced cardiomyocyte apoptosis. Selectively suppressing sAC activity with KH7 during SI or during SR, we found that activity of sAC is specifically required during SI for SI/SR-induced apoptosis of cardiomyocytes. Therefore, it seems that sAC contributed to the triggering (during SI) rather than to the executing (during SR) phase of apoptosis in cardiomyocytes.
It has been shown that mitochondria play a crucial role in ischaemia/reperfusion-induced cardiac apoptosis. 13, 28 Ischaemia-induced injury of mitochondria due to a permeabilization of its outer and inner membrane followed by depolarization and release of pro-apoptotic proteins, e.g. cytochrome c, is a widely accepted scenario of the mitochondria-dependent apoptosis. 13, 28 In agreement with these findings, mitochondrial depolarization and activation of the mitochondrial pathway of apoptosis were also found in our model of SI/SR, which were attenuated by inhibition of sAC during SI.
Overall, these findings demonstrate that sAC contributes to the SI-induced mitochondrial injury and activation of the mitochondrial pathway of apoptosis.
To further understand the sAC-dependent signalling leading to activation of the mitochondrial pathway of apoptosis, the role of PKA, a major down-stream target of sAC, was investigated in the present study. PKA signalling is controlled by PKA-anchoring proteins, which tether PKA pools and localize them at discrete subcellular microdomains in close proximity to kinase-specific down-stream substrates. 31, 32 Previous reports demonstrated a compartmentalization of PKA within mitochondrial microdomains 30, 33, 34 and its role in mitochondrial apoptosis. 30, 35, 36 Mitochondrial translocation of sAC found in the present study under anoxic stress (see Supplementary material online, Figure S5 ) may, therefore, lead to a selective activation of PKA localized within these mitochondrial microdomains. Applying treatment with two PKA inhibitors with different sites of action, we found that PKA plays an essential role in mitochondrial Bax translocation and activation of the mitochondrial pathway of apoptosis. Several models have been proposed for a PKA-dependent induction of the mitochondrial pathway of apoptosis. PKA activation may inhibit the pro-survival kinase Akt, 37 which in turn controls mitochondrial translocation of several pro-apoptotic Bcl-2-family proteins. Furthermore, Arokium et al. 23 reported recently that PKA may promote mitochondrial Bax translocation through phosphorylation at Ser(60). Activation and mitochondrial translocation of Bax has been identified as a key event in activation of the intrinsic pathway of apoptosis in Soluble adenylyl cyclase controls apoptosis in vitro and in vivo models of cardiac ischaemia/reperfusion. 38, 39 In line with these reports, a translocation of Bax to the mitochondria was found during SI in our study, which was prevented by inhibition of either sAC or PKA. Moreover, SI led to Bax phosphorylation at Thr(167) in a sAC-and PKA-dependent manner. This finding suggests an involvement of a PKA-dependent Bax phosphorylation in the SI-induced mitochondrial Bax translocation. In agreement with our data, a previous study of Kim et al. 40 demonstrated that the phosphorylation of Bax at this site by JNK and p38-kinase promotes its translocation to mitochondria. A direct suppression of the mitochondrial Bax binding due to treatment with a specific Bax-inhibiting peptide prevented the cardiomyocyte apoptosis. Altogether, these findings suggest that SI-induced translocation of Bax to the mitochondria in adult cardiomyocytes is dependent on sAC/PKA activity and is a key event in sAC-dependent apoptosis. Reperfusion in cardiomyocytes may lead to a burst of ROS production, which can be a cause as well as a trigger of mitochondrial injury. 41, 42 In line with previous reports a marked ROS formation was observed during the initial phase of reperfusion. Inhibition of sAC or suppression of mitochondrial Bax binding prevented SR-induced ROS formation. Furthermore, scavenging ROS with NAC abolished SI/SR-induced caspase-3 cleavage. Thus, SR-induced ROS formation seems to be an important event in the sAC-dependent apoptosis down-stream to mitochondrial Bax translocation.
In conclusion, the present study described a novel signalling pathway controlling the mitochondrial pathway of apoptosis induced in adult cardiomyocytes during SI. In the anoxic phase, sAC translocates to mitochondria and promotes the PKA-dependent Bax-phosphorylation and Bax-binding to mitochondria, which causes ROS formation followed by mitochondrial cytochrome c release and apoptosis during SR.
